10.1097/00006676-199103000-00013 30 GersteinH
The nanoparticles predominantly accumulated in the liver, where they effectively reduced hepatic steatosis by modulating fat metabolism genes (such as by increasing CPT-1 and suppressing SREBP-1c), with a 100 mg/kg dose showing markedly stronger effects than an equivalent free berberine dose
Fat grafting for facial rejuvenation through injectable tissue replacement and regeneration: a differential, standardized, anatomic approach
Specifically, the 4mg dose is being tested as a step-down option after initial weight loss on higher doses
The American College of Physicians guidelines note that continued treatment is necessary to maintain weight loss, as discontinuation often leads to weight regain
This pharmacovigilance system allows patients, carers, and healthcare professionals to report any suspected side effects from medicines, vaccines, and medical devices including those that are unlicensed or used off-label